Ketoprofen
1 NDC across 1 manufacturer|1 Generic,0 Brand
Ketoprofen is used to treat rheumatoid arthritis, dysmenorrhea and osteoarthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 9, 1986, and the first generic was approved Dec 22, 1992. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Ketoprofen across 2,274 claims for 752 beneficiaries.
Ketoprofen is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $6.46 to $6.46 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$6.46 – $6.46
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing KETOPROFEN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KETOPROFEN ER 200 MG CAPSULE | $6.4618 per EA | — |
Frequently Asked Questions
What is Ketoprofen used to treat?
Ketoprofen is used to treat rheumatoid arthritis, dysmenorrhea and osteoarthritis, per the National Library of Medicine's MED-RT classification.
When did Ketoprofen become available as a generic?
FDA approved the first generic Ketoprofen (ANDA) on Dec 22, 1992. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ketoprofen?
In 2024, Medicare Part D spent $2 million on Ketoprofen across 2,274 claims for 752 beneficiaries.
How many Ketoprofen products are on the market?
The Ketoprofen drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Ketoprofen?
NADAC reference prices for Ketoprofen range from $6.4618 to $6.4618 per EA.
Which manufacturers make Ketoprofen?
1 manufacturer lists Ketoprofen in NADAC. Ranked by number of NDCs, the largest are Mylan Pharmaceuticals Inc. (1).